Extreme Elevations in Blood Pressure and All-Cause Mortality in a Referred CKD Population: Results from the CRISIS Study
Open Access
- 22 April 2013
- journal article
- research article
- Published by Hindawi Limited in International Journal of Hypertension
- Vol. 2013, 1-8
- https://doi.org/10.1155/2013/597906
Abstract
Hypertension frequently complicates chronic kidney disease (CKD), with studies showing clinical benefit from blood pressure lowering. Subgroups of patients with severe hypertension exist. We aimed to identify patients with the greatest mortality risk from uncontrolled hypertension to define the prevalence and phenotype of patients who might benefit from adjunctive therapies. 1691 all-cause CKD patients from the CRISIS study were grouped by baseline blood pressure—target (190 and/or 100 mmHg). Groups were well matched for age, eGFR, and comorbidities. 77 patients had extreme hypertension at recruitment but no increased mortality risk (HR 0.9,) over a median follow-up period of 4.5 years. The 1.2% of patients with extreme hypertension at recruitment and at 12-months had a significantly increased mortality risk (HR 4.3,). This association was not seen in patients with baseline extreme hypertension and improved 12-month blood pressures (HR 0.86,). Most CKD patients with extreme hypertension respond to pharmacological blood pressure control, reducing their risk for death. Patients with extreme hypertension in whom blood pressure control cannot be achieved have an approximate prevalence of 1%. These patients have an increased mortality risk and may be an appropriate group to consider for further therapies, including renal nerve ablation.
Keywords
This publication has 27 references indexed in Scilit:
- Renal sympathetic denervation as second‐line therapy in mild resistant hypertension: A pilot studyCatheterization and Cardiovascular Interventions, 2012
- Cardiovascular Risk in Chronic Kidney Disease: Role of the Sympathetic Nervous SystemCardiology Research and Practice, 2012
- Blood pressure goal in chronic kidney disease: what is the evidence?Current Opinion in Nephrology and Hypertension, 2011
- Systolic Blood Pressure and Mortality Among Older Community-Dwelling Adults With CKDAmerican Journal of Kidney Diseases, 2010
- Republished paper: Arterial stiffness in chronic kidney disease: causes and consequencesHeart, 2010
- Fluid Retention Is Associated With Cardiovascular Mortality in Patients Undergoing Long-Term HemodialysisCirculation, 2009
- Arterial Hypertension Induced by Erythropoietin and Erythropoiesis-Stimulating Agents (ESA)Clinical Journal of the American Society of Nephrology, 2009
- Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso studyNephrology Dialysis Transplantation, 2008
- Impact of Achieved Blood Pressure on Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy TrialJournal of the American Society of Nephrology, 2005
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationThe New England Journal of Medicine, 2004